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Objective: The treatment of patients with arch and thoracoabdominal aortic aneurysms (TAAAs) and chronic dissections
is challenging. We report the results of fenestrated and branched endovascular aortic repair (FEVAR) of such
aneurysms.
Methods: A single-center prospective FEVAR trial enrolled 356 patients (2006 to 2011), of whom 30 had chronic
dissections with arch aneurysm or TAAAs, or both. Patients were divided into group A, 15 patients (mean age, 58 years)
with extensive dissections extending from the arch through the visceral segment, and group B, 15 patients (mean age, 74
years old) with focal dissections and no extension into the thoracic aorta. Inclusion criterion was aneurysm size >5.5 cm in
diameter. Customized grafts were implanted into the true lumen, and branches were extended into the true lumen of the
supra-aortic trunk (arch branch devices) and visceral vessels. Patients were monitored annually with clinical, imaging, and
laboratory studies. Outcome analyses included survival, rupture, spinal cord ischemia, endoleak, morbidity (cardiac, renal
or pulmonary), reinterventions, dissection, and aneurysm growth.
Results: The mean time from the onset of dissection to the FEVAR performed in group A was 10.4 years. The mean
maximum aneurysm diameter was 60 mm. Follow-up averaged 1.7 years. There were no perioperative deaths. One aortic-
related death occurred at 87 days due to progression of a pre-existing untreated arch dissection. No ruptures, cardiac,
renal, pulmonary, or spinal cord ischemia complications occurred. Despite the initially narrow true lumen dimensions,
stent grafts expanded to their nominal diameters after implantation without any blood ﬂow disturbance of branched
visceral vessels and distal aorta. No graft compression occurred. Post-FEVAR growth was noted in two patients, related
to type II endoleaks. Sac regression was similar (L6.8 vs L11.4 mm; P [ .43), but early endovascular reinterventions
were more common in group A (8 patients). Patients with extensive dissection were younger, and the dissection more
likely to be associated with a deﬁned connective tissue disease (Marfan syndrome or Loeys-Dietz mutations, 40% vs 0%;
P [ .006).
Conclusions: FEVAR is feasible for patients with chronic dissections and TAAA. Concerns regarding visceral vessel access
and graft compression resulting from narrow true lumen diameters were not relevant in our experience. Favorable sac and
lumen morphologic changes, coupled with a low mortality and complication risk, makes this an attractive means of
handling this clinical problem. (J Vasc Surg 2013;58:625-34.)Since the advent of thoracic endovascular aortic repair
(TEVAR) for aortic dissections,1,2 TEVAR has proven to
be an excellent alternative to open surgery in anatomically
suitable candidates.3-6 TEVAR has also been applied to
patients with acute complicated type B aortic dissectionsthe Departments of Vascular Surgerya and Thoracic and Cardiovas-
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compared with emergency open surgical procedures.10-12
However, once a chronic dissection develops into a
TAAA, open surgery has remained the mainstay of treat-
ment and is one of the most demanding procedures
for patients and clinicians. Despite the surgical advances,
the risk of morbidity and death remains high.13,14
TEVAR for chronic type B aortic dissection is not well
understood, and challenges include the inability to predict
dissection membrane behavior, disparate true and false
lumen end-organ perfusion, and small-diameter true lumens
with multiple fenestrations. These issues become pertinent
when aneurysmal disease extends beyond the thoracic aorta
to involve the visceral aortic segment.15-17 In our experi-
ence, the thoracic portion of chronic aortic dissections
treated with TEVAR have favorable morphologic changes
along the segment that is covered by stent grafts, yet distally,
slow growth is the rule rather than the exception.18
Fenestrated and branched endovascular aortic repair
(FEVAR) has been successfully applied to small numbers
of patients with TAAAs and chronic dissections.19,20 No
large series on multicenter studies exist, resulting in625
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chronic dissections. This report describes our experience
with chronic aortic dissections and TAAAs.
METHODS
Patient population. A prospectively collected study
was analyzed for patients who underwent FEVAR for jux-
tarenal and thoracoabdominal aneurysms during an
11-year period (2001 to 2011). Patients were enrolled
into a physician-sponsored investigational device exemption
trial for juxtarenal/thoracoabdominal aneurysms (National
Institutes of Health study number: NCT00583050).19,20
However, chronic dissection patients were not treated with
these devices until 2006; thus, only patients with evidence of
dissection requiring visceral or arch branch incorporation
between 2006 and 2011 are included. Informed consent
approved by our Institutional Review Board was obtained
for each patient. Inclusion criteria for this study have been
previously published.19 Patients undergoing emergency
repair were excluded.
Deﬁnition and classiﬁcation of chronic dissection.
Patients were divided into two groups by the extent of their
dissection. Patients in group A had extensive dissections,
which were deﬁned as extending through the visceral
segments with type II or type III TAAA, in accordance
with the Crawford classiﬁcation.21 If the arch was also
involved, such as cases with residual arch dissections after
open proximal dissection repair, this was noted. Group B
patients had focal dissections, which included intimal tears
with or abutting the visceral segment that did not extend
proximally into the thoracic aorta22 (Fig 1).
Anatomic assessment and device design. High-
resolution computed tomography (CT) scans of the chest,
abdomen, and pelvis were obtained. Centerline of ﬂow
algorithms based on the true lumen were used to deﬁne
the longitudinal and radial relationships of the relevant
visceral or supra-aortic trunk vessels. Reinforced fenestra-
tions were preferentially used for all renal arteries and the
visceral vessels in patients with small true lumens. Helical
side-arm branches were used for the visceral vessels in
extensive dissections with TAAA when the lumen size was
>35 mm.20 Only three patients (group A) were treated
with helical side branches, and the rest were treated with
reinforced fenestrations. In the setting of side branches,
Fluency stent grafts (C. R. Bard, Murray Hill, NJ) were
used to mate the aortic component with the target vessel,
and reinforced fenestrations were mated with Jomed
(Abbott Vascular, Santa Clara, Calif) and used in accor-
dance with standard methods of mating branches and
fenestrations with the visceral vessels. Adjunctive stents
were used selectively in areas of kinking or severe tortuosity
and invariably were nitinol self-expanding stents.
Endovascular procedure. Procedures were performed
in a hybrid operating room with ﬁxed imaging equipment.
Preservation of the left subclavian artery and pelvic
circulation was emphasized by using extra-anatomic
bypass (carotid-subclavian) or distal branched grafts (iliac
branched devices). Endografts were always sized to theaorta proximal to the dissection with a 10% to 15% over-
sizing and not tapered to accommodate any changes in the
true lumen dimensions. Cerebrospinal ﬂuid drainage with
appropriate hemodynamic management was established
when the region of aortic coverage was >20 cm. Access
was transfemoral except when conduits were required as
a result of small or calciﬁed iliac arteries, and such proce-
dures were often staged.
FEVAR was performed using custom-made Zenith
branched and fenestrated endografts and standardized
bifurcated and iliac branch devices (Cook Medical Inc,
Bloomington, Ind). If the dissected lesion involved the
arch and the arch was aneurysmal, the total arch endovascu-
lar repair using a custom arch branched graft (Cook
Medical) incorporating with two arch vessels (brachioce-
phalic and left common carotid artery) was performed for
patients presenting in 2010 and later (Fig 2). Cerebrospinal
ﬂuid drainage was used when >20 cm of the thoracic aorta
was covered or in the setting of a compromised internal iliac
artery and was maintained for 48 to 72 hours. Technical
success was deﬁned as a successful branched graft deploy-
ment with all target vessels incorporated and 24-hour
survival in the angiographic absence of type I endoleak.
Variables studied. Preoperative variables collected
included demographics, maximum aortic diameter, and
extent of required aortic repair. The true lumen diameter
was not measured because it was very dynamic. Therefore,
there was not a size cutoff for a minimal true lumen diam-
eter in this study. Three-dimensional modalities in CT
angiography, including multiplanar reconstructions and
centerline of ﬂow analyses, were used to measure the
maximum diameter of the aneurysm sac and the presence of
endoleaks at all time points, in accordance with Society for
Vascular Surgery reporting standards.23,24 In the absence of
speciﬁc contraindications, CT scans were performed at 1, 6,
and 12 months, and yearly thereafter. Triple-phase contrast
studies were used with the delayed phase (5 minutes),
which was preferentially to the arterial phase in the deter-
mination of the status (patent/thrombosed) of the false
lumen. In addition, duplex ultrasound imaging was used
to assess branch vessel status (patency, stenosis, residual
distal branch dissection). Laboratory studies were obtained
annually. All information was stored in an Oracle Clinical
database (Oracle Corp, Redwood Shores, Calif), which
provided most of the demographic, morphologic, and
follow-up data for this patient population. Medical records
and radiographic studies were reviewed to supplement
information speciﬁc to this analysis.
Outcomes. Outcomes included all-cause mortality,
rupture, morbidity (cardiac, renal, pulmonary and spinal
cord ischemia), endoleaks (primary/secondary), reinter-
ventions, and aortic morphologic changes. Deaths and
other variables (unless noted) were classiﬁed in accordance
with the Society for Vascular Surgery reporting stan-
dards.23,24 In addition to the review of medical records
and quarterly phone calls, the United States Social
Security Death Index was automatically queried every 3
months to supplement results. Adverse clinical events
Fig 1. The classiﬁcation of chronic type B aortic dissection. A, left panel, Extensive dissection is deﬁned as an aortic
dissection extending from the arch (right upper panel) through the visceral segments (right middle and lower panels)
with type II or type III thoracoabdominal aortic aneurysm (TAAA). If the arch was also involved in aneurysmal change
with the TAAA, the extent of the aortic disease is classiﬁed as “extensive aorta.” B, Focal dissection is deﬁned as an
aortic dissection limited to an intimal tear that abutted the visceral segment (upper left and upper right panels) that may
extend into the iliac vessels (lower right panel) but not into the thoracic aorta (lower left panel).
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spinal cord ischemia) occurring during the postoperative
period and throughout follow-up were recorded.
Statistical analysis. Demographic and perioperative
characteristics are presented as number with percentage
or mean 6 standard deviation and, when appropriate,
were compared with t-tests. Categoric variables, expressed
as percentages, were analyzed with the c2 test. Actuarial
survival was estimated with Kaplan-Meier analysis curve.
The log-rank test was used to evaluate differences between
Kaplan-Meier curves. SAS 9.0 software (SAS Institute Inc,
Cary, NC) and S-plus 7.0 software (Insightful Corp,
Seattle, Wash) were used for statistical analyses.
RESULTS
Of 356 patients with TAAAs, FEVAR was used to
treat 30 consecutive patients (26 men [87%]) with aortic
dissections affecting the thoracoabdominal segment. Ex-
tensive dissections were present in 15 patients (group A),
four of whom had a surgical history of arch repair and
one of whom had chronic proximal dissection with arch
dilation requiring branched arch graft. Focal dissections
were treated in 15 patients (group B). The mean follow-
up was 1.7 6 1.5 years (range, 1 month-5.2 years) and
postoperative aneurysm diameters were 60 6 15 mm.
The mean time from the onset of dissection to the FEVAR
was 10.4 6 9.9 years (range, 2-34 years) for group A. The
time from dissection to FEVAR was not calculated for
group B because most of the patients never presented
with symptoms of an acute dissection.Baseline patient demographics are detailed in Table I.
Technical success was achieved in all patients, although
the ability to detect type I and III endoleaks in patients
with extensive dissections and many branches was limited.
Signiﬁcant differences between the two groups existed.
Group A consisted of younger patients with a higher likeli-
hood of having genetic conﬁrmation of a connective tissue
disease (P ¼ .006). More patients in group A also had
undergone thoracic aortic repairs involving the root,
ascending aorta or arch, and descending repairs compared
with group B (proximal thoracic: 67% vs 20%; P ¼ .01;
descending thoracic: 80% vs 7%; P < .001).
Mortality. There were no 30-day deaths. There were
four late deaths. Three were unrelated to aortic issues and
one resulted on postoperative day 87 from progression of
an untreated portion of a prior arch dissection that was
remote from the endovascular repair. The three unrelated
deaths included congestive heart failure (a condition pre-
existing the FEVAR), sepsis, and Wegener gran-
ulomatosis. Actuarial survivals at 12, 24, and 36 months
were 85%, 85%, 85% for group A and 100%, 100%, 75%
for group B (log-rank test, P ¼ .50; Fig 3).
Morbidity. No patients developed spinal cord ischemia,
respiratory failure, renal failure, or stroke. The Marfan
syndrome patient who died as a result of congestive heart
failure on postoperative day 65 had previously undergone
multiple cardiac and aortic procedures and had a baseline
ejection fraction of 15%. He was undergoing the endovascu-
lar TAAA repair (which was his sixth aortic operation) with
the intent of subsequently receiving a heart transplant.
Fig 2. Fenestrated and branched endovascular aortic repair (FEVAR) for chronic type B dissection extending from
arch to descending thoracic and thoracoabdominal aorta (extensive dissection) with branched arch graft are shown in
preoperative and postoperative (top) computed tomography (CT) and (bottom) volume-rendered images.
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10 primary endoleaks (ﬁve type I and ﬁve type III) in group
A. All endoleaks were to the visceral portion of the repair
(see Reintervention below). One secondary type III endo-
leak occurred due to distal sealing failure at a re-entry site
within a dissected right renal artery (Table II).
Reinterventions. Of 10 primary endoleaks, eight
patients (ﬁve type I and three type III) underwent repair,
with four patients requiring multiple endovascular procedures
(Table III). One patient with a type III endoleak attributed to
the right renal artery did not undergo reintervention because
of favorable morphologic changes at 6 months (decreased sac
size and markedly decreased endoleak volume). Persistent
type II endoleaks from multiple intercostal arteries into
aneurysmal sac and false lumen were treated with translumbar
glue embolization in two of these patients.
Aneurysm sac behavior. Of the 21 patients (10
patients in group A and 11 patients in group B) whowere monitored for >6 months, no aortic growth was
noted in 19 (90%) (8 [80%] in group A and all of group
B). Overall mean sac regression was similar between the
two groups (6.8 mm in group A vs 11.4 mm in group
B; P ¼ .43; Fig 4). Both patients with growth in group A
had connective tissue diseases (one Marfan syndrome and
the other a TGFbR2 mutation), and both underwent
FEVAR to treat visceral patch aneurysms that developed
after open surgical repairs of type II TAAAs. Both
have undergone multiple reinterventions in an effort to
control the aneurysm morphology, and one has recently
been noted to have a decreasing sac size after his last
intervention.
DISCUSSION
The current treatment paradigm for TAAA in the
setting of a chronic dissection involves open surgical
repair,25-28 or more recently, hybrid endovascular repair
Table I. Patient demographics
Variablea Group A (extensive) (n ¼ 15) Group B (focal) (n ¼ 15) P
Age, years 58 6 11 (33-71) 74 6 8 (53-84) <.001
Male sex 14 (93) 12 (80) .28
Aneurysm diameter, mm 64 6 13 (43-97) 56 6 17 (24-93) .15
Comorbidities
Hypertension 13 (87) 12 (80) .62
Hyperlipidemia 7 (47) 12 (80) .06
Smoking (ever) 10 (67) 10 (67) >.99
Diabetes mellitus 1 (7) 3 (20) .28
Coronary artery disease 2 (13) 11 (73) <.001
Renal insufﬁciencyb 2 (13) 3 (20) .62
Prior paraplegia 3 (20) 0 .07
COPD 0 2 (13) .14
Connective tissue disease 6 (40) 0 .006
Marfan syndrome 4 (27) 0
Loyez-Dietz syndrome 2 (13) 0
Aortic disease
TAAA 15 (100) 5 (33) .003
Crawford type
I 1 (7) 0
II 10 (67) 0
III 0 2 (13)
IV 3 (20) 3 (20)
Extensive aorta (arch þ TAAA II) 1 (7) 0
Juxtarenal abdominal aorta 0 9 (60) <.001
Common iliac artery 0 1 (7) .31
Previous aortic surgery
Proximal thoracic aortic repair 10 (67) 3 (20) .01
Bentall operation 6 (40) 1 (7)
Ascending aorta with arch repair 4 (27) 2 (14)
Descending thoracic aortic repair 12 (80) 1 (7) <.001
Open surgery 8 (53) 0
TEVAR 4 (27) 1 (7)
Abdominal aortic repair 6 (40) 4 (27) .44
Open surgery 4 (27) 2 (13)
EVAR 2 (13) 2 (13)
Cerebrospinal ﬂuid drainage used 11 (73) 3 (20) .003
COPD, Chronic obstructive pulmonary disease; EVAR, endovascular abdominal aortic repair; TAAA, thoracoabdominal aortic aneurysm; TEVAR, thoracic
endovascular aortic repair.
aContinuous data are shown as mean 6 standard deviation (range) and categoric data as number (%).
bDeﬁned as creatinine >1.5 mg/dL.
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 3 Kitagawa et al 629(mesenteric/renal bypass).29-32 Both these techniques are
associated with signiﬁcant risk, and many patients are not
candidates for either procedure. The outcomes of open
repair or hybrid endovascular procedure for TAAA in liter-
ature are reported in Table IV. Hybrid endovascular proce-
dures29-32 have been thought to be less invasive than open
repair for TAAA because of the minimal chest dissection
and lack of aortic cross-clamping. However, the 30-day
mortality (8.5%-24%) and incidence of spinal cord ischemia
(4.3%-14%) remain signiﬁcant. Clearly, there is a need for
a less invasive solution for dissection with TAAA, and
FEVAR seems to be a promising possibility.
FEVAR is an established treatment for nondissected
TAAA.20,33,34 Concerns speciﬁc to dissection repair
include the potential for true lumen stent graft compres-
sion, inadequate end-organ blood ﬂow to visceral vessels
supplied from the false lumen, and more challenging tech-
nical issues with implantation.35 From our data, it appearsthat the key to successful false lumen obliteration is to
ensure that the endovascular repair extends well above
and below the dissection ﬂaps. Thus, in a focal dissection
where the ﬂap is limited to a portion of the visceral
segment, one simply incorporates the visceral vessels into
the repair within the true lumen, the ﬂap and false lumen
collapse, and the proximal and distal sealing zones are
extended above and below the dissection. Success was
noted in all group B patients. There were no instances of
graft compression, no endoleaks, and no branch compro-
mise, and repair was always associated with favorable
morphologic behavior on follow-up.
This principle is much more difﬁcult to apply in
a patient with extensive dissections because the anatomy
and patient presentations are markedly more complex. Six
patients in group A underwent treatment for proximal
(ascending) dissections with interposition grafts in the
ascending aorta, with only the “normal segment” of target
Table II. Endoleaks after fenestrated and branched
endovascular aortic repair (FEVAR) for chronic type B
aortic dissection in group A (no endoleaks in group B)
Endoleak
Group A (extensive) (n ¼ 15)
No. (%)
Primary 10 (66.7)a
Type I 5 (33.3)
Type IA 1 (6.7) Proximal landing zone
Type IB 4 (26.6) Iliac landing zone
Hypogastric branch distal
Type III 5 (33.3) Renal branch
Celiac branch
SMA branch
Secondary 1 (6.7) Renal branch
SMA, Superior mesenteric artery.
aStaged endoleaks (two endoleaks were found separately) (n ¼ 3).
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Fig 3. Actuarial survival curves of fenestrated and branched
endovascular aortic repair (FEVAR) in the Kaplan-Meier analysis
are shown for group A (n ¼ 15; black line) and group B (n ¼ 15;
dotted line), with the error bars showing the standard error.
Table III. Reinterventions after fenestrated and branched
endovascular aortic repair (FEVAR) for chronic type B
aortic dissection in groupA (no reinterventions in groupB)
Reintervention
Group A (extensive) (n ¼ 15)
No. Repair
First reintervention 8 Iliac leg extension
Type I 5 Hypogastric interruption
Re-TEVAR
Type III 3 Celiac artery stent
Renal artery re-PTA
SMA stent
Second reintervention 4
Type III 4 Renal artery stent with IMA CEa
Renal artery stent
Renal artery re-PTA
Translumbar CE with plug
Third reintervention 2
Type II 2 Translumbar CE
CE, Coil embolization; IMA, inferior mesenteric artery; PTA, percutaneous
transluminal angioplasty; TEVAR, thoracic endovascular aortic repair.
aCoil or glue embolization.
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aorta or other surgically implanted graft. However, in the
absence of arch dilation, it seems inappropriate to treat
the entire aortic segment. All but one of these patients
also had thoracic repairs providing a segment within the
thoracic aorta providing a landing zone in that region
that was dissection-free, providing an optimal proximal
landing zone for an endovascular graft. There were no
issues with proximal sealing, ﬁxation, or migration in cases
where a prior surgical or endovascular landing zone had
been successfully created. When we were forced to use
the native aorta for a landing zone, we tried to locate the
landing zone in the healthiest segment possible (straight,
nonsurgical, nonatheromatous) and maintain at least 2 cm
of sealing within the healthiest aorta ascertainable.
Aside from the proximal sealing and ﬁxation zone,
there exist three regions of potential failure: the intergraft
joints, the interface between a branch and the distal visceral
or brachiocephalic artery, and the distal sealing zone. Thelatter situation becomes challenging when the dissection
extends into and beyond the iliac vessels, often necessi-
tating the incorporation of the internal iliac arteries into
the repair. In such a case, we found that the off-the-shelf
helical iliac branch device (Cook Medical Inc) version
worked well with respect to the ability to cannulate the
internal iliac artery36 within small true lumens (smallest
was 5 mm) while allowing for treatment deep into the
dissected internal iliac artery systems using self-expanding
stent grafts.
When the dissection extends deep into a visceral vessel,
particularly when it involves secondary and deeper
branches, the repair becomes more challenging. Unlike dis-
section within the internal iliac artery, where the anterior or
posterior division may be sacriﬁced and a seal established
within one of the internal iliac trunks, the side branches
on the visceral vessels may not be occluded without poten-
tially signiﬁcant repercussion (mesenteric or renal insufﬁ-
ciency). Unfortunately, we have no optimal solution in
such circumstances. If a seal cannot be established solely
within the true lumen, the objective becomes preventing
aneurysm perfusion derived from retrograde ﬂow through
the false lumen.
One patient with dissection deep into the left renal and
superior mesenteric arteries (SMAs) required an innovative
solution. The left renal dissection was amenable to exten-
sion of the covered stents deep into the artery to the level
of the renal bifurcation. However, the SMA dissection
extended to the ileocolic vessel, and the false lumen
supplied many proximal small intestinal branches. Thus,
once the aortic repair was completed and the SMA branch
reinforced with two stent grafts, a lumbar puncture was
performed. The false lumen of the SMA was accessed and
occluded using embolization techniques (Fig 5). This
excluded the aortic aneurysm, but the fate of the SMA
-30
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Average: -6.8mm decrease Average: -11.4mm decrease(P=0.43) 
Fig 4. Depicted is sac behavior in all patients with $6-month follow-up for group A (n ¼ 10) and group B (n ¼ 11).
A white bar means decrease (<5 mm), a gray bar as stable (5 to 5 mm), and a black bar is an increase (>5 mm).
Although the mean sac regression was similar between two groups (6.8 mm in group A vs 11.4 mm in group B;
P ¼ .43), the only two patients with growth were in group A, both in patients with patch aneurysms and connective
tissue diseases.
Table IV. Outcomes after open repair or hybrid
endovascular repair for thoracoabdominal aortic
aneurysm (TAAA) in literature
First
author Year
Patients,
No.
Operative
procedure
Mortality, %
SCI, %30-day In-hospital
Cowan25 2003 1542 Open NA 22 NA
Rigberg26 2006 1010 Open 19 NA NA
Conrad27 2007 445 Open 6.8 8.8 13.2
Coselli28 2007 2286 Open 5 6.6 3.8
Smith29 2011 24 Hybrid 12.5 NA 8.3
Lin30 2012 58 Hybrid 24 NA NA
Hughes31 2012 47 Hybrid 8.5 NA 4.3
Oderich32 2012 159 Hybrid 16 NA 14
NA, Not available; SCI, spinal cord ischemia.
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is generally not an access issue, because there is usually
a fenestration created by the dissection or one can create
an endovascular fenestration, but the long-term manage-
ment of such vessels is suspect and conceptually leaves
much to be desired. Although this prevents growth of
the aortic aneurysm, visceral dilation is not necessarily
treated with this method.
The interface between graft components can also pose
challenges. There are many components in these repairs
that frequently transcend extremely tortuous anatomy.
Optimally, extensive overlap between components willeliminate joint endoleaks and provide durable repairs, but
luminal constraints and target vessel size often prevent
this design. The true lumen in a chronic dissection is typi-
cally obliquely shaped and narrow, creating technical chal-
lenges with stent design and implantation. Thus, in some
cases, it seems helpful to optimize the true lumen to allow
placement of a branched device. After our experience with
TEVAR for chronic thoracic dissections,18 we used a design
strategy of using a long straight (nontapered) graft for the
thoracic portion of the disease. The procedure was then
staged by a period of w2 months, with the intent of
allowing the true lumen to expand but also potentially
minimizing the risk of spinal cord ischemia. However,
this is only a recent strategy and was used in one of the
patients in this series, although many of the group A
patients would be considered staged with respect to their
surgical thoracic repairs. Consistently, in surgical or endo-
vascular thoracic repairs of chronic dissection, we have
seen expansion of the true lumen near the distal seal, but
more distally, slow aortic growth is the rule rather than
the exception. Thus, in cases where we considered the
true lumen in the visceral segment to be too small to
form or manipulate catheters, we defaulted to a staged
repair whereby TEVAR would initially be completed to
the level of the celiac artery.
Extensive dissections, particularly in the setting of the
syndromic connective tissue diseases, add yet another level
of complexity. The aortic wall in patients with connective
tissue disease like Marfan syndrome or Loyez-Dietz
Fig 5. A persistent endoleak through the distal re-entry of the superior mesenteric artery (SMA; *) resulted in
retrograde ﬁlling into the false lumen (white arrows) after fenestrated endovascular aneurysm repair for chronic type B
aortic dissection is shown in a (A) computed tomography (CT) and (B) angiogram. The translumbar embolization
using coils and AMPLATZER Vascular Plug (St. Jude Medical, St. Paul, Minn) plugs (black arrows) was performed to
occlude the false lumen near the origin of the SMA. The angiogram shows the (C) right anterior oblique view and
(D) the frontal view.
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using endovascular techniques. Yet, many of these patients
are considered nonsurgical candidates and relegated to die
from their dissections or aneurysms. Endovascular repairs
have been attempted. Marcheix et al37 reported the
outcomes of stent grafting of the dissected descending
aorta in 15 patients with Marfan syndrome. Primary endo-
leaks occurred in 5 patients, secondary endoleaks devel-
oped in 5, and 7 required conversion to open repair.
Our series included six patients with diagnosed connec-
tive tissue diseases. Five of these 6 patients had undergone
proximal and distal aortic repairs, providing acceptable
landing zones, yet continued growth of untreated aorta
was noted over time. Ultimately, it appears that if the
patients live long enough, they will require total aortic
replacement. The patch aneurysms that were treated did
not enjoy a favorable morphologic response and represent
a challenging group of patients to deal with. Open surgicaltechniques have evolved to eliminate the patch in such
patients and branches are individually sewn to each vessel
given the likelihood of patch failure in connective tissue
disease patients.
There were no conversions to open surgery, partly
because the patients were considered nonsurgical candi-
dates preoperatively, which is why we are continuing to
monitor the one remaining patient with growth and the
second patient who only recently was noted to have sac
size decrease. Interestingly, both patients had prior open
repairs of type II TAAA and presented with large (8-10
cm) patch aneurysms. After endovascular repair, the patch
aneurysms continued to expand. Obvious questions
include the integrity of the wall in these patients and the
ability to successfully protect from rupture using endovas-
cular techniques. One of the two patients suffered an
SMA stent separation (multiple stents were required to
bridge the gap between the aortic device and the visceral
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 3 Kitagawa et al 633vessel), which, when treated, resulted in some sac size
decrease.
Of the 15 patients in group A, there were 10 primary
endoleaks (5 type I and 5 type III, 3 in connective tissue
disease patients). These leaks were all detected on CT scan-
ning, likely not appearing on angiographic studies given
the extensive length of the repair with an inability to image
the entire region without excessive amounts of contrast.
After the CT diagnosis, efforts were made to repair any
type I or III endoleak, which in some patients required
multiple procedures. Such patients must understand that
multiple procedures and detailed follow-up will be neces-
sary. Yet, alternative open surgical techniques suffer from
similar shortcomings.
CONCLUSIONS
FEVAR is feasible for patients with chronic type B
aortic dissections with TAAAs. Focal dissections have
favorable results, provided that adequate landing zones
are located above and below the dissected tissue. The
patients with extensive dissections, particularly those with
connective tissue diseases and those with dissection deep
into the visceral arteries, remain challenging. Such patients
will often require multiple procedures, but when aneurysm
exclusion is achieved, the aortic morphologic changes
appear to be favorable. The behavior of the chronically
dissected false lumen appears to parallel that of the more
acutely dissected aorta when all of the false lumen fenestra-
tions are properly occluded, implying that a watch-and-
wait philosophy is reasonable in the setting of an acute
dissection where there is only a potential for the develop-
ment of a visceral segment aneurysm. This becomes
a particularly sound strategy when there are minimally inva-
sive options capable of treating the chronically dissected
TAAA.
AUTHOR CONTRIBUTIONS
Conception and design: AK, RG
Analysis and interpretation: AK, RG
Data collection: AK, RG
Writing the article: AK, RG, ME, TM, ER
Critical revision of the article: AK, RG, ME, TM, ER
Final approval of the article: AK, RG
Statistical analysis: AK, RG
Obtained funding: RG
Overall responsibility: RG
REFERENCES
1. Dake MD, Kato N, Mitchell RS, Semba CP, Razavi MK, Shimono T,
et al. Endovascular stent-graft placement for the treatment of acute
aortic dissection. N Engl J Med 1999;340:1546-52.
2. Nienaber CA, Fattori R, Lund G, Dieckmann C, Wolf W, von
Kodolitsch Y, et al. Nonsurgical reconstruction of thoracic aortic
dissection by stent-graft placement. N Engl J Med 1999;340:1539-45.
3. Song TK, Donayre CE, Walot I, Kopchok GE, Litwinski RA,
Lippmann M, et al. Endograft exclusion of acute and chronic aortic
descending thoracic aortic dissections. J Vasc Surg 2006;43:247-58.4. Estrera AL, Miller CC, Goodrick J, Porat EE, Achouh PE,
Dhareshwar J, et al. Update on outcomes of acute type B aortic
dissection. Ann Thorac Surg 2007;83:S842-5.
5. Kische S, Ehrlich MP, Nienaber CA, Rousseau H, Heijmen R,
Piquet P, et al. Endovascular treatment of acute and chronic aortic
dissection: midterm results from the Talent thoracic retrospective
registry. J Thorac Cardiovasc Surg 2009;138:115-24.
6. Zipfel B, Czerny M, Funovics M, Coppi G, Ferro C, Rousseau H, et al.
Endovascular treatment of patients with type A and B thoracic aortic
dissection using Relay thoracic stent-grafts: results from RESTORE
patient registry. J Endovasc Ther 2011;18:131-43.
7. Cambria RP, Crawford RS, Cho JS, Bavaria J, Farber M, Lee WA, et al.
A multicenter clinical trial of endovascular stent-graft repair of acute
catastrophes of the descending thoracic aorta. J Vasc Surg 2009;50:
1255-64.
8. Ehrlich MP, Dumfarth J, Schoder M, Gottardi R, Holfeld J,
Juraszek A, et al. Midterm results after endovascular treatment of acute,
complicated type B aortic dissection. Ann Thorac Surg 2010;90:
1444-8.
9. Steuer J, Eriksson MO, Nyman R, Björck M, Wanhainen A. Early and
long-term outcome after thoracic endovascular aortic repair (TEVAR)
for acute complicated type B dissection. Eur J Vasc Endovasc Surg
2011;41:318-23.
10. Miller DC, Mitchell RS, Oyer PE, Stinson EB, Jamieson SW,
Shumway NE. Independent determinants of operative mortality for
patients with aortic dissection. Circulation 1984;70:I153-64.
11. Hsu RB, Ho YL, Chen RJ, Wang SS, Lin FY, Chu SH. Outcome of
medical and surgical treatment in patients with acute type B aortic
dissection. Ann Thorac Surg 2005;79:790-5.
12. Trimachi S, Nienaber CA, Rampoldi V, Mymel T, Suzuki T,
Bossone E, et al. IRAD Investigators. Role and results of surgery in
acute type B aortic dissection: insights from the International registry
of Acute Aortic Dissection (IRAD). Circulation 2006;114(1 suppl):
I357-64.
13. Zoli S, Etz CD, Roder F, Mueller CS, Brenner RM, Bodian CA, et al.
Long-term survival after open repair of chronic distal aortic dissection.
Ann Thorac Surg 2010;89:1458-66.
14. Wong DR, Parenti JL, Green SY, Chowdhary V, Liao JM, Zarda S,
et al. Open repair of thoracoabdominal aortic aneurysm in the modern
surgical era: contemporary outcomes in 509 patients. J Am Coll Surg
2011;212:569-81.
15. Kusagawa H, Shimono T, Ishida M, Suzuki T, Yasuda F, Yuasa U,
et al. Changes in false lumen after transluminal stent-graft placement
in aortic dissections; six years’ experience. Circulation 2005;111:
2951-7.
16. Sayer D, Bratby M, Brooks M, Loftus I, Morgan R, Thompson M,
et al. Aortic morphology following endovascular repair of acute and
chronic type B aortic dissection: implications for management. Eur J
Vasc Endovasc Surg 2008;36:522-9.
17. Oberhuber A, Winkle P, Schelzig H, Orend KH, Muehling BM.
Technical and clinical success after endovascular therapy for chronic
type B aortic dissections. J Vasc Surg 2011;54:1303-9.
18. Kang WC, Greenberg RK, Mastracci TM, Eagleton MJ,
Hernandez AV, Pujara AC, et al. Endovascular repair of complicated
chronic distal aortic dissections: intermediated outcomes and compli-
cations. J Thorac Cardiovasc Surg 2011;142:1074-83.
19. Greenberg RK, Lu Q, Roselli EE, Svensson LG, Moon MC,
Hernandez AV, et al. Contemporary analysis of descending thoracic
and thoracoabdominal aneurysm repair: a comparison of endovascular
and open techniques. Circulation 2008;118:808-17.
20. Greenberg RK, Eagleton ME, Mastracci TM. Branched endografts for
thoracoabdominal aneurysms. J Thorac Cardiovasc Surg 2010;140:
S171-8.
21. Crawford ES, Crawford JL, Saﬁ HJ, Coselli JS, Hess KR, Brooks B,
et al. Thoracoabdominal aortic aneurysms: preoperative and intra-
operative factors determining immediate and long-term results of
operations in 605 patients. J Vasc Surg 1986;3:389-404.
22. Svensson LG, Labib SB, Eisenhauer AC, Butterly JR. Intimal tear
without hematoma: an important variant of aortic dissection that can
elude current imaging techniques. Circulation 1999;99:1331-6.
JOURNAL OF VASCULAR SURGERY
634 Kitagawa et al September 201323. Chaikof EL, Blankensteijin JD, Harris PL, White GH, Zarins CK,
Bernhard VM, et al. Ad Hoc Committee for Standardized Reporting
Practices in Vascular Surgery of The Society for Vascular Surgery/
American Association for Vascular Surgery. Reporting standards for
endovascular aortic aneurysm repair. J Vasc Surg 2002;35:1048-60.
24. Fillinger MF, Greenberg RK, McKinsey JF, Chaikof EL; Society for
Vascular Surgery Ad Hoc Committee on TEVAR. Reporting standards
for thoracic endovascular aortic repair (TEVAR). J Vasc Surg 2010;52:
1022-33.
25. Cowan JA, Dimick JB, Henke PK, Huber TS, Stanley JC,
Upchurch GR. Surgical treatment of intact thoracoabdominal aortic
aneurysms in the United States: hospital and surgeon volume-related
outcomes. J Vasc Surg 2003;37:1169-74.
26. Rigberg DA, McGory ML, Zingmond DS, Maggard MA, Agustin M,
Lawrence PF, et al. Thirty-day mortality statistics underestimate the
risk of repair of thoracoabdominal aortic aneurysms: a statewide
experience. J Vasc Surg 2006;43:217-23.
27. Conrad MF, Crawford RS, Davison JK, Cambria RP. Thor-
acoabdominal aneurysm repair. A 20-year perspective. Ann Thorac
Surg 2007;83:S856-61.
28. Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286
thoracoabdominal aortic aneurysms. Ann Thorac Surg 2007;83:
S862-4. discussion: S890-2.
29. Smith TA, Gatens S, Andres M, Modrall JG, Clagett GP, Arko FR.
Hybrid repair of thoracoabdminal aortic aneurysms involving the
visceral vessels: comparative analysis between number of vessels
reconstructed, conduit, and gender. Ann Vasc Surg 2011;25:64-70.
30. Lin PH, Kougias P, Bechara CF, Weakly SM, Bakaeen FG,
LeMaire SA, et al. Clinical outcome of staged vs combined treatment
approach of hybrid repair of thoracoabdominal aortic aneurysm withvisceral vessel debranching and aortic endograft exclusion. Perspect
Vasc Surg Endovasc Ther 2012;24:5-13.
31. Hughes GC, Barﬁeld ME, Shah AA, Williams JB, Kuchibhatla M,
Hanna JM, et al. Staged total abdominal debranching and thoracic
endovascular aortic repair for thoracoabdominal aneurysm. J Vasc Surg
2012;56:621-9.
32. Oderich GS, Timaran C, Farber M, Quinones-Baldrich W, Escobar G,
Gloviczki P, et al. Spinal cord injury after hybrid endovascular repair of
thoracoabdominal aortic aneurysm in the North American Complex
Abdominal Aortic Debranching (NACAAD) registry. Presented at the
2012 Vascular Annual Meeting of the Society for Vascular Surgery,
National Harbor, Md, Jun 7-9, 2012.
33. Reilly LM, Rapp JH, Grenon SM, Hiramoto JS, Sobel J, Chuter TA.
Efﬁcacy and durability of endovascular thoracoabdominal aortic aneu-
rysm repair using the caudally directed cuff technique. J Vasc Surg
2012;56:53-64.
34. Guillou M, Bianchini A, Sobocinski J, Maurel B, D’elia P, Tyrrel M,
et al. Endovascular treatment of thoracoabdominal aortic aneurysms.
J Vasc Surg 2012;56:65-73.
35. Kasirajan K, Milner R, Chaikof EL. Late complications of thoracic
endografts. J Vasc Surg 2006;43:94A-9A.
36. Oderich GS, Greenberg RK. Endovascular iliac branch devices for iliac
aneurysms. Perspect Vasc Surg Endovasc Ther 2011;23:166-72.
37. Marcheix B, Rousseau H, Bongard V, Heijmen RH, Nienaber CA,
Ehrlich M, et al. Stent grafting of dissected descending aorta in patients
with Marfan’s syndrome: mid-term results. J Am Coll Cardiol Interv
2008;1:673-80.Submitted Sep 10, 2012; accepted Jan 27, 2013.
